World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
55537
World Ranking
8127
National Ranking
315

Overview

G. Kees Hovingh is affiliated with the University of Amsterdam in the Netherlands, specializing in medical research with a significant focus on cardiovascular and metabolic health. Their research interests span multiple interconnected fields including surgery, genetics, cardiology and cardiovascular medicine, economics and econometrics, and endocrinology, diabetes, and metabolism.

The scientist's work covers a range of topics primarily related to lipid metabolism and cardiovascular conditions. Key themes in their research include:

  • Lipoproteins and Cardiovascular Health
  • Lipid Metabolism and Disorders
  • Cancer, Lipids, and Metabolism
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Atherosclerosis and Cardiovascular Diseases
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical Economics and Policy

Hovingh has contributed to numerous scientific publications, with a notable presence in specialized journals. The frequent venues for their work include:

  • Atherosclerosis
  • Journal of Clinical Lipidology
  • The Lancet Diabetes & Endocrinology
  • European Journal of Preventive Cardiology
  • Circulation

Some recent representative papers by or involving Hovingh address critical aspects of familial hypercholesterolemia, statin therapy effects, and cardiovascular disease progression. These include:

  • "Long-Term Evolocumab in Patients With Familial Hypercholesterolemia" (2020) published in Journal of the American College of Cardiology
  • "Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia" (2020) published in New England Journal of Medicine
  • "Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis" (2024) published in The Lancet Diabetes & Endocrinology
  • "Marked plaque regression in homozygous familial hypercholesterolemia" (2021) published in Atherosclerosis
  • "Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT" (2022) published in The Lancet Diabetes & Endocrinology

Throughout their career, Hovingh has frequently collaborated with several coauthors, indicating active participation in multi-investigator research projects. Notable frequent coauthors include:

  • Frederick J. Raal
  • Laurens F. Reeskamp
  • Albert Wiegman
  • John J.P. Kastelein
  • Daniel Gaudet

In summary, G. Kees Hovingh's academic contribution centers on medical research with special emphasis on cardiovascular health, lipid disorders, and their systemic metabolic implications, reflected in a consistent output of publications and collaborative research activity.

Best Publications

  • Biological, clinical and population relevance of 95 loci for blood lipids

    Tanya M. Teslovich;Kiran Musunuru;Albert V. Smith;Andrew C. Edmondson

  • Discovery and refinement of loci associated with lipid levels

    Cristen J. Willer;Ellen M. Schmidt;Sebanti Sengupta;Gina M. Peloso;Gina M. Peloso;Gina M. Peloso

  • Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

    Borge G. Nordestgaard;M. John Chapman;Steve E. Humphries;Henry N. Ginsberg

  • Defining the role of common variation in the genomic and biological architecture of adult human height

    Andrew R. Wood;Tonu Esko;Jian Yang;Sailaja Vedantam

  • Large-scale association analysis identifies new risk loci for coronary artery disease

    Panos Deloukas;Stavroula Kanoni;Christina Willenborg;Martin Farrall

  • Genetic studies of body mass index yield new insights for obesity biology

    Adam E. Locke;Bratati Kahali;Sonja I. Berndt;Anne E. Justice

  • Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    Erik S. Stroes;Paul D. Thompson;Alberto Corsini;Georgirene D. Vladutiu

  • Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    Marina Cuchel;Eric Bruckert;Henry N. Ginsberg;Frederick J. Raal

  • Common variants associated with plasma triglycerides and risk for coronary artery disease

    Ron Do;Cristen J. Willer;Ellen M. Schmidt;Sebanti Sengupta

  • Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways

    Robert A Scott;Vasiliki Lagou;Ryan P Welch;Eleanor Wheeler

  • Familial Hypercholesterolaemia in Children and Adolescents: Gaining Decades of Life by Optimizing Detection and Treatment

    Albert Wiegman;Samuel S. Gidding;Gerald F Watts;M John Chapman

  • PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2) : a randomised, double-blind, placebo-controlled trial

    Frederick J Raal;Evan A Stein;Robert Dufour;Traci Turner

  • Inhibition of PCSK9 With Evolocumab in Homozygous Familial Hypercholesterolaemia (TESLA Part B): A Randomised, Double-Blind, Placebo-Controlled Trial

    Frederick J Raal;Narimon Honarpour;Dirk J Blom;G Kees Hovingh

  • Measurement of Arterial Wall Thickness as a Surrogate Marker for Atherosclerosis

    Eric de Groot;G. Kees Hovingh;Albert Wiegman;Patrick Duriez

  • Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: A meta-analysis of statin trials

    S. Matthijs Boekholdt;G. Kees Hovingh;Samia Mora;Benoit J. Arsenault

  • HDL and cardiovascular disease

    Daniel J Rader;G Kees Hovingh

  • Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction

    Ron Do;Ron Do;Nathan O. Stitziel;Hong Hee Won;Hong Hee Won;Anders Berg Jørgensen

  • Homozigot ailevi hiperkolesterolemi: klinisyenlerin tanıyı ve klinik yönetimi geliştirmelerine yönelik yeni anlayışlar ve rehberlik. Avrupa Ateroskleroz Derneği’nin Ailevi Hiperkolesterolemi Üzerine Uzlaşı Paneli yazılı görüşü

    Marina Cuchel;Eric Bruckert;Henry N. Ginsberg;Frederick J. Raal

  • ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia

    John J.P. Kastelein;Henry N. Ginsberg;Gisle Langslet;G. Kees Hovingh

  • The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

    Robert A. Hegele;Henry N. Ginsberg;M. John Chapman;Børge G. Nordestgaard

Frequent Co-Authors

John J.P. Kastelein
John J.P. Kastelein University of Amsterdam
Nilesh J. Samani
Nilesh J. Samani University of Leicester
Erik S.G. Stroes
Erik S.G. Stroes University of Amsterdam
Nicholas J. Wareham
Nicholas J. Wareham University of Cambridge
Paul W. Franks
Paul W. Franks Lund University
Panos Deloukas
Panos Deloukas Queen Mary University of London
Sekar Kathiresan
Sekar Kathiresan Harvard University
Tonu Esko
Tonu Esko University of Tartu
Markus Perola
Markus Perola Finnish Institute for Health and Welfare
Daniel I. Chasman
Daniel I. Chasman Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in the medical field have a variety of online degree options and alternative career pathways to consider. Many easy nursing programs to get into are available for those seeking a quicker entry into healthcare, offering less competitive admission requirements while still providing a pathway to licensure.

For those who prefer administrative or behind-the-scenes roles, consider medical billing and coding. You may wonder, can you get financial aid for medical billing and coding? Many accredited online programs do offer financial aid opportunities, making this a more accessible option for career changers or those balancing other commitments.

If you’re interested in starting as a Licensed Practical Nurse (LPN), some programs may not require entrance exams. Learn more: do you have to take a teas test for lpn.

Lastly, leadership positions in healthcare are within reach sooner with expedited online options. Explore the benefits of earning a healthcare administration accelerated degree to start making an impact as a healthcare manager or administrator.

Best Scientists Citing G. Kees Hovingh

Trending Scientists